Ignite Creation Date:
2025-12-25 @ 12:41 AM
Ignite Modification Date:
2026-01-06 @ 7:30 PM
Study NCT ID:
NCT03547167
Status:
COMPLETED
Last Update Posted:
2021-01-15
First Post:
2018-05-24
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study to Evaluate the Safety, Tolerability, and Immunogenicity of V114 Followed by PNEUMOVAX™23 in Adults at Increased Risk for Pneumococcal Disease (V114-017/PNEU-DAY)
Sponsor:
Merck Sharp & Dohme LLC
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-07-16
Start Date Type:
ACTUAL
Primary Completion Date:
2020-01-20
Primary Completion Date Type:
ACTUAL
Completion Date:
2020-01-20
Completion Date Type:
ACTUAL
First Submit Date:
2018-05-24
First Submit QC Date:
None
Study First Post Date:
2018-06-06
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2020-12-14
Results First Submit QC Date:
None
Results First Post Date:
2021-01-15
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-12-21
Last Update Post Date:
2021-01-15
Last Update Post Date Type:
ACTUAL